Morgan Stanley Starts MyoKardia (MYOK) at Overweight
Morgan Stanley analyst Jeffrey Hung initiates coverage on MyoKardia (NASDAQ: MYOK) with a Overweight rating and a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)